CME Group Inc. $CME Shares Sold by Lansforsakringar Fondforvaltning AB publ

Posted by George Bondi on Jun 30th, 2026

Lansforsakringar Fondforvaltning AB publ lowered its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 2.3% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 112,796 shares of the financial services provider’s stock after selling 2,713 shares during the period. Lansforsakringar Fondforvaltning AB publ’s holdings in CME Group were worth $33,314,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the stock. Pinnacle Bancorp Inc. lifted its position in shares of CME Group by 28.1% during the first quarter. Pinnacle Bancorp Inc. now owns 369 shares of the financial services provider’s stock worth $109,000 after purchasing an additional 81 shares during the last quarter. Apollon Wealth Management LLC increased its holdings in CME Group by 4.5% in the first quarter. Apollon Wealth Management LLC now owns 13,996 shares of the financial services provider’s stock valued at $4,134,000 after buying an additional 605 shares during the last quarter. AGH Wealth Advisors LLC increased its holdings in CME Group by 8.3% in the first quarter. AGH Wealth Advisors LLC now owns 1,994 shares of the financial services provider’s stock valued at $589,000 after buying an additional 152 shares during the last quarter. Cornerstone Wealth Group LLC raised its stake in CME Group by 3.3% during the first quarter. Cornerstone Wealth Group LLC now owns 15,780 shares of the financial services provider’s stock valued at $4,488,000 after buying an additional 508 shares in the last quarter. Finally, Goodman Advisory Group LLC raised its stake in CME Group by 175.0% during the first quarter. Goodman Advisory Group LLC now owns 429 shares of the financial services provider’s stock valued at $127,000 after buying an additional 273 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other news, Director William R. Shepard acquired 325 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The shares were acquired at an average price of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Keefe, Bruyette & Woods raised CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price on the stock in a report on Thursday, June 18th. Raymond James Financial upped their price target on CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research report on Monday, April 6th. The Goldman Sachs Group reduced their price objective on CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a research note on Thursday, April 23rd. Jefferies Financial Group decreased their price objective on shares of CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a report on Thursday, April 9th. Finally, TD Cowen lowered their target price on shares of CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Twelve research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $302.24.

Read Our Latest Report on CME

CME Group Stock Down 1.1%

Shares of CME Group stock opened at $218.58 on Tuesday. The stock has a market capitalization of $79.20 billion, a price-to-earnings ratio of 18.65, a PEG ratio of 2.47 and a beta of 0.21. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The business’s 50 day simple moving average is $271.58 and its 200-day simple moving average is $285.49.

CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business’s revenue for the quarter was up 14.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.80 EPS. Equities research analysts forecast that CME Group Inc. will post 12.28 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were issued a dividend of $1.30 per share. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 2.4%. CME Group’s payout ratio is 44.37%.

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.